Spesolimab Post-marketing Surveillance in Korean Patients With Flares With Generalized Pustular Psoriasis
Clinical trial NCT06886009 · WITHDRAWN
Trial details
- NCT number
- NCT06886009
- Sponsor
- Boehringer Ingelheim
- Status
- WITHDRAWN
- Study type
- OBSERVATIONAL
- Start date
- 2026-03-31
- Primary completion
- 2029-06-08
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.